Skip to main content
. Author manuscript; available in PMC: 2010 Jun 4.
Published in final edited form as: Immunol Lett. 2009 Apr 5;124(2):57–62. doi: 10.1016/j.imlet.2009.03.013

Figure 1.

Figure 1

Model of a human dimeric S-IgA molecule with assigned adaptive (specific-antibody) activity and innate (glycan-dependent) activity [88]. Asterisk – possible N-glycosylation sites within the CDR3 segment of the VH region of α chains [97, 98, 128].